Breaking News - The Fly

Open Search

VIGL

Vigil Neuroscience

$

()

Vigil says interim IGNITE Phase 2 data demonstrate VGL101 potential for ALSP

VIGL

4/17/2024 - 16:15pm

Vigil Neuroscience sees cash runway into 2H25

VIGL

3/26/2024 - 07:07am

Vigil Neuroscience reports Q4 EPS (57c), consensus (53c)

VIGL

3/26/2024 - 07:07am

Vigil Neuroscience appoints Kaufmann as Chief Medical Officer

VIGL

3/20/2024 - 07:17am

Acrivon Therapeutics appoints Magovcevic to board of directors

ACRV , VIGL

2/8/2024 - 08:15am

Vigil Neuroscience extends projected cash runway into second half of 2025

VIGL

1/3/2024 - 16:35pm

Vigil Neuroscience just downgraded at Morgan Stanley, here's why

VIGL

12/19/2023 - 07:09am

Vigil Neuroscience announces interim data from IGNITE trial

VIGL

11/16/2023 - 16:33pm

Vigil Neuroscience reports Q3 EPS (53c), consensus (57c)

VIGL

11/7/2023 - 07:23am

Arm initiated, SQM downgraded: Wall Street's top analyst calls

ARM , PINS , ESTC

…

10/18/2023 - 09:52am

Vigil Neuroscience initiated with an Outperform at JMP Securities

VIGL

10/18/2023 - 04:56am

Vigil Neuroscience announces first patient dosed in Phase 1 trial of VG-3927

VIGL

10/17/2023 - 07:15am

Vigil Neuroscience receives positive opinion from EMA on ODD for VGL101

VIGL

9/26/2023 - 07:08am

Vigil presents VGL101 complete Phase 1 data, Phase 2 IGNITE trial design

VIGL

9/11/2023 - 12:02pm

Vigil Neuroscience says VG-3927 IND now open, clinical trial allowed to proceed

VIGL

9/8/2023 - 16:07pm